🦊/Lists

Biotech Investors & VC Firms in United States

1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.

Grazia Equity GmbH
StuttgartSeed–Late Stage$540K – $2.7M
8 people
Fast Track Initiative
TokyoPre-Seed–Growth$1.2M – $184M
2 people
Triventures
HerzliyaPre-Seed–Series A$1M – $3M
10 people
Co-Win Ventures
SuzhouSeed–Series B
WELL Ventures
VancouverSeed–Growth
16 people
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
PAI Partners
ParisGrowth–Late Stage$108M – $324M
13 people
Version One Ventures
VancouverPre-Seed–Seed$250K – $500K
3 people
Fountain Healthcare Partners
DublinSeed–Series B$10.8M – $16.2M
8 people
Kinled Holding
Hong KongSeed–Series A
1 person
Monte Carlo Capital
Pre-Seed–Series A$350K – $1.5M
3 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
Brunnur Ventures GP
ReykjavikPre-Seed–Series A$1M – $3M
9 people
SCP Vitalife Partners
Tel AvivSeed–Late Stage$3M – $7M
11 people
AIR Capital
Buenos AiresPre-Seed–Series A
2 people
Pallasite Ventures
VancouverSeed–Series A$100K – $1.5M
1 person
Highline Beta
TorontoPre-Seed–Growth
17 people
Kinnevik
StockholmSeed–Late Stage
2 people
Roche Venture Fund
BaselSeed–Growth$648K – $3.2M
10 people
3B Future Health Fund
MonacoPre-Seed–Late Stage$12M
12 people
SABIC Ventures
SittardSeed–Late Stage$500K – $20M
10 people
Apex Innovative Investments Ventures
VancouverPre-Seed–Series A$250K
9 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
15 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage$1.9M – $227M

Related lists

Data sourced from public filings and firms' own websites — see our methodology.